| |
|
|
|
Plx Pharma Inc  
|
|
20.03 2.23 (0.13%) |
09-28 16:00 |
|
Open: |
20.7 |
Pre close: |
17.8 |
Target:
|
24.74
|
|
High: |
20.8746 |
Low: |
19.6 |
Resistance:
|
21.18
24.74
|
|
Volume: |
367,317 |
Market Cap: |
460M |
Support:
|
17.99
16.02
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
19.97
 |
MACD |
MACD(12,26):
|
0.66 |
|
MA(20): |
18.39 |
Signal(12,26,9): |
0.37 |
|
MA(100): |
15.69 |
Stochastic Oscillator |
%K(14,3):
|
87.43  |
|
MA(250): |
10.22 |
%D(3): |
88.29 |
|
Average Volume(K) |
3-Month: |
1596882
|
52-Week |
High:
|
21.50 |
|
10-Days: |
42272 |
Low: |
3.00 |
|
RSI |
RSI(14):
|
61.47 |
Change(%): |
520.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.570 |
Return on Equity (ttm) |
-124.2 |
Shares Out. (M) |
22.98 |
|
EPS Est. Current Year |
-1.610 |
Return on Assets (ttm) |
-20.6 |
Shares Float (M) |
22.14 |
|
EPS Est. Next Year |
-1.820 |
PEG Ratio |
0.00 |
% Held by Insiders |
15.48 |
|
EPS Est. Next Quarter |
-0.460 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
42.39 |
|
Forward EPS |
-3.840 |
Gross Profit (p.s.) |
0.001 |
Shares Short (K) |
1670 |
|
Book Value (p.s.) |
1.960 |
EBITDA (p.s.) |
-0.733 |
P/E |
-7.79 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
10.22 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-15.40 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-9.39 |
P/CF |
-29.89 |
|
|
|
|
|
|
